WAVE Life Sciences Ltd (FRA:1U5)
€ 12.8 -0.1 (-0.78%) Market Cap: 1.89 Bil Enterprise Value: 1.62 Bil PE Ratio: 0 PB Ratio: 13.52 GF Score: 41/100

WAVE Life Sciences Ltd at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 25, 2021 / 10:00PM GMT
Release Date Price: €7.65 (-0.65%)
Mani Foroohar
SVB Leerink - Analyst

Good afternoon and welcome back to our ongoing series of company presentations and fireside chats for this year's Global Healthcare conference. I am Mani Foroohar, senior analyst covering the drug medicine space.

And I have with me Paul Bolno, CEO of WAVE Life Sciences, which has, amongst other things, a number of the most impactful data catalysts in my whole coverage this year. And possibly one of the most poorly understood pathways for catalysts over the course of the next 12 months -- anywhere in our entire coverage.

Paul, if you want to give people a heads up on why I think that, (multiple speakers) tap into my brain and see why I think that about the year ahead.

Paul Bolno
WAVE Life Sciences Ltd. - President & CEO

We appreciate it. And thank you for the introduction. And obviously we'll be making forward-looking statements during the fireside chat. I think a lot of the work that went into what we will be talking about for 2021 and beyond was really that foundation led last year in 2020.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot